Shorter tuberculosis treatment not a successful alternative, clinical drug trial shows

23 octubre 2014

A shortened (four month) treatment for tuberculosis is well tolerated and may work well in subsets of tuberculosis patients, but overall could not be considered as an alternative to the current six month standard treatment, a clinical drug trial conducted in five Sub-Sahara African countries shows.